Incidence and distribution of occluded culprit arteries and impact of coronary collaterals on outcome in patients with non-ST-segment elevation myocardial infarction and early invasive treatment strategy

2010 ◽  
Vol 100 (5) ◽  
pp. 457-467 ◽  
Author(s):  
Philipp Bahrmann ◽  
Justus Rach ◽  
Steffen Desch ◽  
Gerhard C. Schuler ◽  
Holger Thiele
Keyword(s):  
Myocardial Infarction ◽  
Treatment Strategy ◽  
Invasive Treatment ◽  
St Segment Elevation ◽  
Coronary Collaterals ◽  
Segment Elevation Myocardial Infarction ◽  
St Segment

scholarly journals NSTEMI Guideline During the Covid-19 Pandemia, the Missing Piece What’s New in the 2020 ESC Practice Guidelines?

2021 ◽  
Vol 18 (3) ◽  
pp. 51-56
Author(s):  
Mădălina Badea ◽  
Ana-Maria Balahura ◽  
Daniela Bartoş
Keyword(s):  
Myocardial Infarction ◽  
Risk Stratification ◽  
Practice Guidelines ◽  
Cardiac Biomarkers ◽  
Invasive Treatment ◽  
St Segment Elevation ◽  
Segment Elevation Myocardial Infarction ◽  
St Segment ◽  
Therapeutic Tools ◽  
European Society Of Cardiology

Abstract According to tradition, every year, at the Congress of the European Society of Cardiology new clinical guidelines, usefull for our daily pratice, are launched. This year a new guideline for the management of non-ST-segment elevation myocardial infarction (NSTEMI) was presented. Substantial resources had been invested to sustain the research efforts in order to improve the diagnosis and therapeutic tools for this disease. In this article we present the main differences between this guideline and the previous one, regarding the utility of the cardiac biomarkers, diagnosis and risk stratification algorithms, and last, but not least, medical and invasive treatment tools.

Sign in / Sign up

Export Citation Format

Share Document